Fund Holdings — MPM ASSET MANAGEMENT LLC

Total Portfolio Value
$69.44M
Total Bought
$2.15M
Total Sold
$3.04M
Net Transaction
-$891.9K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Repare Therapeutics, Inc.1,683,7071,121,318-562,3892,2061,1061.59%-1,100
Adaptimmune Therapeutics plc(ADAPY)5,555,4615,335,715-219,7462,9941,0511.51%-1,943
Werewolf Therapeutics, Inc.(HOWL)4,284,1724,309,860+25,6886,3414,1896.03%-2,151
iTeos Therapeutics, Inc.2,738,7852,738,785021,03416,35123.55%-4,683
Dyne Therapeutics, Inc.(DYN)682,376682,376016,0777,13810.28%-8,939
Entrada Therapeutics, Inc.(TRDA)4,381,0624,381,062075,74939,60557.04%-36,144
Page 1 of 1
MPM ASSET MANAGEMENT LLC — 13F Holdings — Q1 2025 | TickerTrail